Mayne Pharma Group Ltd MAYNF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $4.47
- Day Range
- $4.54–4.54
- 52-Week Range
- $1.90–4.59
- Bid/Ask
- $4.38 / $4.82
- Market Cap
- $386.24 Mil
- Volume/Avg
- 250 / 2,160
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.09
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 1.12%
Company Profile
Mayne Pharma Group Ltd is a specialty pharmaceutical company focused on commercializing novel and generic pharmaceuticals It has a Forty-year track record of innovation and success in developing oral drug delivery systems. The Company's Business consists of three operating segments being International, Branded Products (BPD) and Portfolio Products Division (PPD). The Portfolio Products Division distributes dermatology products (branded and generic) in the US on a portfolio basis, The Branded Products Division distributes branded women’s health products in the US. International’s segment revenue and gross profit are derived principally from the Australian manufacture and sale of branded and generic pharmaceutical products.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Small Value
- Total Number of Employees
- 160
- Website
- http://www.maynepharma.com
Comparables
Valuation
|
Metric
|
MAYNF
|
4554
|
524348
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 7.56 | 26.12 |
Price/Book Value | 0.99 | 0.90 | 3.80 |
Price/Sales | 2.09 | 0.91 | 1.74 |
Price/Cash Flow | — | 3.91 | 19.68 |
Price/Earnings
MAYNF
4554
524348
Financial Strength
|
Metric
|
MAYNF
|
4554
|
524348
|
|---|---|---|---|
Quick Ratio | 1.15 | 0.68 | 0.87 |
Current Ratio | 1.61 | 1.46 | 1.61 |
Interest Coverage | −6.99 | 55.27 | 8.39 |
Quick Ratio
MAYNF
4554
524348
Profitability
|
Metric
|
MAYNF
|
4554
|
524348
|
|---|---|---|---|
Return on Assets (Normalized) | −16.16% | 3.39% | — |
Return on Equity (Normalized) | −31.76% | 7.02% | — |
Return on Invested Capital (Normalized) | −27.83% | 4.22% | — |
Return on Assets
MAYNF
4554
524348
Drug Manufacturers - General Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
LLY
| Eli Lilly and Co | Btstvtcwnc | Zyq | $696.2 Bil | |
JNJ
| Johnson & Johnson | Kdgcnrnw | Zfck | $357.9 Bil | |
MRK
| Merck & Co Inc | Vtsxnycpg | Hhtps | $321.5 Bil | |
ABBV
| AbbVie Inc | Ypkgmxb | Wrvn | $297.3 Bil | |
AZN
| AstraZeneca PLC ADR | Wwzbsngshm | Fcvh | $219.1 Bil | |
NVS
| Novartis AG ADR | Wbrqmdcnk | Psfn | $199.4 Bil | |
RHHBY
| Roche Holding AG ADR | Fxnchzxn | Nrjqn | $196.3 Bil | |
PFE
| Pfizer Inc | Drpkbvy | Xvrc | $148.7 Bil | |
AMGN
| Amgen Inc | Gcqzmdwktk | Hbvjp | $146.4 Bil | |
SNY
| Sanofi SA ADR | Csjznyj | Myd | $117.2 Bil |